Chester County News and Community Website
WASHINGTON, D.C. — The U.S. Food and Drug Administration this week issued guidance for medical product developers, specifically covering vaccines, diagnostics and therapeutics products, to address the emergence and potential …
Read More
COATESVILLE, PA — Brandywine Hospital – Tower Health is fortunate to have received doses of the recently approved COVID-19 drug bamlanivimab, a monoclonal antibody to treat individuals diagnosed with COVID-19.
Read More
WASHINGTON, D.C. — Acting Commissioner of Food and Drugs Janet Woodcock M.D. recently released a statement on the Food and Drug Administration’s work to support medical product development to address …
Read More
WASHINGTON, D.C. — A web-based COVID-19 outpatient treatment locator maintained by the U.S. Department of Health and Human Services (HHS) is now available to assist healthcare providers and patients in finding potential …
Read More
HARRISBURG, PA — Pennsylvania Treasurer Joe Torsella this week co-filed a shareholder proposal at Gilead, maker of remdesivir (brand name: Veklury), the only antiviral drug approved by the Food and …
Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration has issued an emergency use authorization (EUA) for casirivimab and imdevimab to be administered together for the treatment of mild to moderate …
Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration has issued an emergency use authorization (EUA) for the drug baricitinib, in combination with remdesivir, for the treatment of suspected or …
Read More
WASHINGTON, D.C. — The U.S. Department of Health and Human Services this week announced plans to allocate initial doses of Eli Lilly and Company’s investigational monoclonal antibody therapeutic, bamlanivimab, which …
Read More
The U.S. Food and Drug Administration has approved the antiviral drug Veklury (remdesivir) for use in adult and pediatric patients 12 years of age and older and weighing at least …
Read More
WEST CHESTER, PA — A Chester County biopharma company will receive more than $210,000 in grant funding to support the advancement of a treatment in response to the COVID-19 pandemic, …
Read More